ArticleCureus2025
Prevalence of Metabolic Syndrome and Its Associated Factors Among Malagasy Patients With Ischemic Stroke: A Cross-Sectional Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Metabolic syndrome (MetS) and ischemic stroke are significant public health issues due to their high prevalence and impact on morbidity and mortality. The objective of this study was to determine the prevalence of MetS and its associated factors among Malagasy patients with ischemic stroke. Materials and methods This cross-sectional study was conducted over a three-year period at the Soavinandriana Hospital Center, Antananarivo, Madagascar. MetS was defined according to the International Diabetes Federation's 2009 criteria. Ischemic stroke was confirmed by brain computerized tomography. The TOAST classification was used to determine the etiologies. Results We included 307 patients with ischemic stroke. The prevalence of MetS was 77.9%. According to the logistic regression analysis, the factors associated with MetS were female gender (adjusted odds ratio (aOR) = 3.99, p-value = 0.0031), hypertension (aOR = 4.02, p-value = 0.0029), overweight or obesity (aOR = 2.13, p-value = 0.0122), diabetes (aOR = 4.20, p-value = 0.0011), Glasgow scale ≤10 (aOR = 2.18, p-value = 0.0157), National Institutes of Health Stroke Scale (NIHSS) ≥15 (aOR = 2.94, p-value = 0.0086), and modified Rankin scale ≥ 3 (aOR = 2.29, p-value = 0.0033). As components of MetS, elevated blood pressure was significantly associated with overweight or obesity (aOR = 1.97, p-value = 0.0440), large artery atherosclerosis (LAA) (aOR = 10.2, p-value = 0.0256), and cardioembolism (aOR = 0.25, p-value = 0.0177). The associations between elevated fasting glucose and LAA (aOR = 2.26, p-value = 0.0012) and cardioembolism (aOR = 0.34, p-value = 0.0004). Elevated triglycerides was associated significantly with diabetes (aOR = 2.01, p-value = 0.0452), cardioembolism (aOR = 0.45, p-value = 0.0115), and lacunar infarcts (aOR = 3.05, p-value = 0.0336). Conclusion Screening for MetS should be a routine part of assessing patients with ischemic stroke. Proper management of MetS and its components could lead to improvements in the profile and prognosis of ischemic stroke.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.